Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Non-Current Assets (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Non-Current Assets data on record, last reported at $543.4 million in Q4 2025.

  • For Q4 2025, Non-Current Assets changed N/A year-over-year to $543.4 million; the TTM value through Dec 2025 reached -$312.9 million, changed N/A, while the annual FY2025 figure was $550.3 million, 44.36% up from the prior year.
  • Non-Current Assets reached $543.4 million in Q4 2025 per PAHC's latest filing, up from -$835.8 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $550.3 million in Q2 2025 and bottomed at -$835.8 million in Q3 2025.
  • Average Non-Current Assets over 5 years is $214.2 million, with a median of $374.0 million recorded in 2022.
  • Peak YoY movement for Non-Current Assets: skyrocketed 176.07% in 2021, then crashed 254.31% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $340.3 million in 2021, then increased by 11.69% to $380.1 million in 2022, then plummeted by 254.31% to -$586.6 million in 2023, then rose by 2.7% to -$570.8 million in 2024, then skyrocketed by 195.2% to $543.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $543.4 million in Q4 2025, -$835.8 million in Q3 2025, and $550.3 million in Q2 2025.